Bonesupport Holding AB (publ) (STO:BONEX)

Sweden · Delayed Price · Currency is SEK

197.70

-4.70 (-2.32%)

At close: Mar 2, 2026

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	1.17B	898.73M	591.08M	328.82M	212.89M
Pharmaceuticals Growth	30.70%	52.05%	79.76%	54.46%	17.71%
Total	1.17B	898.73M	591.08M	328.82M	212.89M
Total Growth	30.70%	52.05%	79.76%	54.46%	17.71%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	971.91M	715.90M	442.40M	216.90M	121.70M
United States Growth	35.76%	61.82%	103.96%	78.23%	22.07%
Europe & Rest of The World (EUROW)	202.75M	-	-	-	-
Other Europe & Rest of The World	-	82.98M	63.63M	53.64M	45.23M
Other Europe & Rest of The World Growth	-	30.42%	18.62%	18.60%	0.88%
Sweden	-	10.80M	11.60M	9.70M	7.90M
Sweden Growth	-	-6.90%	19.59%	22.78%	0%
United Kingdom	-	89.00M	73.40M	48.60M	38.10M
United Kingdom Growth	-	21.25%	51.03%	27.56%	34.15%
North America Excl. USA	-	44.00K	49.00K	-24.00K	-43.00K
North America Excl. USA Growth	-	-10.20%	-	-	-
Total	1.17B	898.73M	591.08M	328.82M	212.89M
Total Growth	30.70%	52.05%	79.76%	54.46%	17.71%

Source: S&P Global Market Intelligence.